New Onset Diabetes in COVID-19 | August 18, 2021
In this presentation, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, reviews the latest articles related to risk of diabetes or longer-term abnormalities of glycemic control post Covid-19, as well as provides a number of valuable resources related to risk of reinfection after vaccination.
Recording:
Presented by:
Dr. Tom Becker
Thomas Becker, MD, PhD, has spent his entire career as an epidemiologist focused on Indian health issues. He trained in internal medicine, epidemiology, and anthropology and currently serves as a medical epidemiologist at the Northwest Portland Area Indian Health Board. Although Tom has a variety of research interests, the common theme in his work centers around minority health disparities. He has done extensive community-based projects in partnership with NPAIHB and its 43 member tribes. Tom is passionate about mentoring trainees, primarily MPH students and American Indians who sought research training.
Resources Provided:
- Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (MMWR)
- Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 (MMWR)
- A grim warning from Israel: Vaccination blunts, but does not defeat Delta (Science Mag)
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes (Acta Diabetol)
- New-Onset Diabetes in Covid-19 (NEJM)
- Proportion of newly diagnosed diabetes in COVID-19 patients:A systematic review and meta-analysis (Wiley)
- How CovID-19 disrupts glycometabolic control (Nature Metabolism)
- Global Registry of COVID-19-related diabetes (CoviDIAB)
- Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection (Nature Metabolism)
Date added: September 16, 2021